Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,161,021
-
Share change
-
+6,660,040
-
Total reported value
-
$39,885,705
-
Put/Call ratio
-
111%
-
Price per share
-
$1.59
-
Number of holders
-
97
-
Value change
-
+$10,606,525
-
Number of buys
-
55
-
Number of sells
-
19
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q4 2020
As of 31 Dec 2020,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,161,021 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Willis Investment Counsel, CVA Family Office, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Western Wealth Management, LLC, PRIVATE CAPITAL MANAGEMENT LLC, SRS Capital Advisors, Inc., and GROUP ONE TRADING, L.P..
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.